NNESAM Spring Scientific Session & Business Meeting
Saturday, June 5th, 2021
Organized by the Northern New England Society of Addiction Medicine.
ASAM designates this live activity for a maximum of 4 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Required CME Statements and Conflict of Interest Disclosures, Click Here.
Schedule of Events
James Berry MD, President, NNESAM
8:00 AM – 8:05 AM
Building AMNet: A Focus on Office-based Practices – Implications for Research & More with Diana E. Clarke, PhD; Debbie Gibson; and Robert Philip Schwartz, M.D.
8:05 AM – 9:05 AM
Use of Injectable Buprenorphine for Office-based Treatment of Opioid Use Disorder with John Brooklyn, M.D.,
9:05 AM – 10:05 AM
Break 10:05 AM -10:15 AM
The Medical Management of Alcohol Use Disorder-How to Help Your Patients Get Sober with Mark Publicker, M.D., DFASAM, DABAM.
10:15 AM – 11:15 AM
The Role of Decriminalization and Legalization in Addressing Substance Use Disorders with Shawn Ryan, M.D., MBA, ABEM, ABAM.
11:15 – 12:15 PM
NNESAM President’s Closing Remarks
Break 12:15 – 12:30
On Friday, June 4th, all NNESAM Members will be emailed a link to join Zoom, as well as the Business Meeting agenda.
ASAM Members: $40.00
Non-ASAM Members: $80.00
Residents and Fellows: $25.00
Medical Students, Full or Part-time Undergraduate or Graduate Students: $10.00
*Registration will be considered incomplete until fee payment is received. Once payment is collected, registrants can expect a confirmation email from email@example.com. This email will contain the link needed to join Zoom. This link will be sent to all registrants again on Friday, June 4th. Have Questions? Please direct them to NNESAMeventInfo@gmail.com.
Registration Is Now Closed
NNESAM Thanks Our Sponsors!
In compliance with Standards for Commercial Support from the Accreditation Council for Continuing Medical Education (ACCME), Northern New England Society for Addiction Medicine acknowledges unrestricted educational grant support from the following commercial interests:
Acadia Healthcare is one of the largest providers of behavioral health services within the United States, including multiple levels of care (inpatient, outpatient, IOP.) The CTC Group is committed to providing access to quality care for Opioid Use Disorder. Medication Assisted Treatment (MAT) is provided at 21 Comprehensive Treatment Centers (CTCs) in Maine, New Hampshire, Vermont, Massachusetts and Rhode Island. AcadiaHealthcare.com
At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Gilead.com